Onco:Innovate Investor Network 

 

The Onco:Innovate Investor Network is an exclusive international community of investors dedicated to advancing innovation in oncology and related fields across biotech, life sciences, and healthcare.

Bringing together leading venture funds, corporate investors, business angels, and family offices, the network focuses on transformative cancer care solutions and cutting-edge health innovation. Investor network partners gain exclusive access to high-potential startups through demo days, accelerator alumni, and investor-only events. The network also fosters co-investment opportunities, peer connections, and increased visibility through targeted PR for both investors and their portfolio companies.

Below are the valued investment partners of our growing investor community.

Sofia Angels Ventures (SAV) is a venture capital fund backed by the European Investment Fund, designed to co-invest alongside angel investors, family offices, and other private funds. SAV operates on a deal-by-deal co-investment model, partnering with a wide range of private investors and institutions. The fund focuses on technology, AI, and health-tech startups, at the pre-seed and seed stages. In 2025, SAV VC Fund I supports 24 portfolio companies (including oncology startups) and is currently raising VC Fund II, which will maintain a strong emphasis on health-tech, longevity, artificial intelligence, and the future of work.
Noctua Science Ventures (Noctua) is a venture initiative jointly launched by Speedinvest and the TU Wien (Technical University of Vienna). Noctua focuses on supporting deep tech startups emerging from Austria’s top universities and research institutions. By providing early-stage capital and hands-on guidance, they help translate scientific discoveries into real-world impact. The fund’s focus is on IP-intensive deep‑tech ventures across five verticals: Software & AI, Deep Tech, Climate & Industrial Tech, SynBio & Biotech, and HealthTech. Noctua’s mission is to close the funding gap between science and business, transforming academic research into market-ready innovations

Interested in joining?

If you are an investor passionate about shaping the future of oncology, get in touch to learn more about becoming part of the Onco:Innovate Investor Network.

 

Join